Signalling Circuits in Cancer

All cancer tissue phenotypes are initiated by deregulated signalling mechanisms in cancer cells. Signalling mechanisms are also the largest target mechanism entity for targeted cancer therapies. Recent data also strongly indicate that cancer therapy resistance is initiated by non-genetic signaling rewiring via post-translational regulation of proteins involved in signalling networks and transcriptional gene regulation.